---
title: "IMA.US (IMA.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/IMA.US/news.md"
symbol: "IMA.US"
name: "IMA.US"
parent: "https://longbridge.com/zh-CN/quote/IMA.US.md"
datetime: "2026-03-11T10:13:27.905Z"
locales:
  - [en](https://longbridge.com/en/quote/IMA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMA.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/IMA.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMA.US/news.md)


# IMA.US (IMA.US) — 相关新闻

### [ImageneBio | 8-K: FY2025 Revenue: USD 800 K](https://longbridge.com/zh-CN/news/278549681.md)
*2026-03-10T12:20:50.000Z*
### [US banking lobby considers suing OCC over crypto bank charters: Report](https://longbridge.com/zh-CN/news/278480955.md)
*2026-03-10T02:52:17.000Z*
> A US banking trade group, the Bank Policy Institute (BPI), is reportedly considering legal action against the Office of 

### [12 Health Care Stocks Moving In Monday's After-Market Session](https://longbridge.com/zh-CN/news/275362163.md)
*2026-02-09T21:05:50.000Z*
> In Monday's after-market session, several health care stocks experienced notable movements. Silexion Therapeutics (SLXN)

### [Joseph Slattery Spends US$96k On ImageneBio Stock](https://longbridge.com/zh-CN/news/271209748.md)
*2025-12-31T11:40:40.000Z*
> Joseph Slattery, Director of ImageneBio, Inc. (NASDAQ:IMA), recently purchased US$96k worth of stock at US$5.99 per shar

### [Abeona Therapeutics CEO Vishwas Seshadri Reports Sale of Common Shares](https://longbridge.com/zh-CN/news/271031833.md)
*2025-12-29T21:30:51.000Z*
> Vishwas Seshadri, CEO of Abeona Therapeutics Inc., has reported the sale of common shares of the company. The full filin

### [ImageneBio Chief Medical Officer Yufang Lu Resigns](https://longbridge.com/zh-CN/news/270208634.md)
*2025-12-18T21:06:36.000Z*
> ImageneBio Inc. announced the resignation of Chief Medical Officer Yufang Lu, effective December 31, 2025. The company i

### [ImageneBio (NASDAQ:IMA) Rating Lowered to Underperform at Wedbush](https://longbridge.com/zh-CN/news/267550336.md)
*2025-11-26T14:00:03.000Z*
> Wedbush downgraded ImageneBio (NASDAQ:IMA) to "underperform" with a $2.00 target price. Other analysts have mixed rating

### [Sell Recommendation for ImageneBio Due to Strategic Risks and Financial Challenges](https://longbridge.com/zh-CN/news/267456491.md)
*2025-11-26T04:55:14.000Z*
> Wedbush analyst Martin Fan downgraded ImageneBio to a Sell with a $2.00 price target due to strategic risks and financia

### [ImageneBio Highlights IMG-007 in Corporate Update](https://longbridge.com/zh-CN/news/266568793.md)
*2025-11-19T13:18:03.000Z*
> ImageneBio updated its corporate presentation, emphasizing the potential of IMG-007 for treating atopic dermatitis. The